US FDA 510(k) clearance paves the way for an innovative orthopaedic product that offers the potential to improve bone apposition and, as a consequence, patient outcomes 1-3
Faster time-to-market for innovative medical devices through streamlined device- development strategies that consider the total costs of care
New “Polymer Innovation Centre” now operational for pilot-plant scale manufacturing of new PAEK polymers. A milestone in Victrex´s ongoing and intensive programme of pioneering research and development
Partnering with Invibio Biomaterial Solutions enabled the acceleration of the submission process; FDA 510(k) clearance expected in Q4 2017
Jakob Sigurdsson has joined Victrex as CEO-designate; David Hummel to retire after 24 successful years as CEO
Victrex is aligning its resources with the TPRC to benefit the entire Aerospace supply chain and is dedicated to driving development and adoption of new PAEK-based technologies; joint activities will meet industry standards, facilitating adoption by major aircraft manufacturers
New Research in the field of implants: Results reported at the latest International PEEK Meeting reveal gathering momentum in the use of PEEK polymer in trauma implants and the future potential for the additive manufacturing.
Ellington´s fight to get back on track with a new fracture healing technology after being severely injured in a motorbike accident earlier this year and inspiring fellow patients with his passion...
China-based surgeons attended a joint surgical event, planned by NASS and CAOS in May in Guangzhou, and witnessed a live demonstration of China’s Double Medical’s DLIF cage for spinal fusion
Dedicated medical “International PEEK Meeting” in Washington, D.C. to focus on advances, clinical research, material and technology updates in spine, dental, trauma and arthroscopic implants